“Infectious diseases have no geographic boundaries. It doesn’t matter whether a country is rich or poor, developed or developing, these diseases can still arrive.” – Sujan Shresta, Ph.D.
Sujan Shresta joined LIAI in 2005 as an Assistant Member in the Vaccine
Discovery Division. Dr. Shresta's research focuses on the interface
between immunology and virology, with particular interest in viral
immunopathogenesis.
Dr. Shresta obtained her B.A. in Biological Sciences from Smith College
and Ph.D. in Immunology from Washington University in St. Louis. She
completed her post-doctoral training in Virology at the University of
California, Berkeley. She received a Research Scholar Development award
from the NIAID in 2005.
Sujan Shresta, Ph.D., and her team study the immunology of dengue virus
(DEN), a globally important mosquito-borne human pathogen. DEN causes a
spectrum of clinical disease ranging from Dengue Fever (DF), a
self-limited febrile illness, to a life-threatening syndrome called
Dengue Hemorrhagic Fever/Dengue Shock Syndrome (DHF/DSS).
Studies suggest that DHF/DSS is an immunopathogenic disease; however,
the precise role of the immune system in response to DEN infection is
presently unclear. Using a mouse model, Dr. Shresta and her team plan
to dissect the protective versus pathogenic mechanisms of the immune
system in response to this viral infection. Presently, they are
identifying immune mediators that control primary and sequential DEN
infections using mice that are genetically deficient in specific
components of the immune system. A better understanding of the immune
response to DEN is critical for developing much-needed anti-viral
therapies and vaccines.
A second line of research involves the identification of viral
components that modulate the severity of DEN infection. Dr. Shresta and
her team have isolated novel DEN strains that cause a severe disease
phenotype in mice by adapting viral isolates from humans and mosquitoes
into peripheral tissues of mice. They are currently developing a
reverse-genetics system, in which specific viral sequences are
manipulated within the context of a full-length infectious clone of the
virus. Knowledge of the viral determinants of infection should provide
novel avenues for developing anti-virals and vaccines.
View all publications
The link above may include papers by scientists with the same or similar name.
Click researcher's name for e-mail. Dial 858-752-6500 to call.